BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10584292)

  • 1. [Desensitization with allergens: early, specific, effective therapy of immune system almost without side effects. Interview by Dr. Barbara Scholtissek].
    Fiebig H; Kahlert H
    Wien Med Wochenschr; 1999; 149(14-15):447, 449-50. PubMed ID: 10584292
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek].
    Valenta R
    Wien Med Wochenschr; 1999; 149(14-15):450-1. PubMed ID: 10584293
    [No Abstract]   [Full Text] [Related]  

  • 3. LAIS - Posological schedules.
    Bruno M
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):33-4. PubMed ID: 17761105
    [No Abstract]   [Full Text] [Related]  

  • 4. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?
    Cox LS
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal dosing of allergen immunotherapy: efficacy, safety, long-lasting effect.
    Senna G; Crivellaro MA; Bonadonna P; Dama AR; Schiappoli M; Passalaqua
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):386-92. PubMed ID: 14768524
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors for systemic reactions to allergen-specific subcutaneous immunotherapy.
    Iglesias-Cadarso A; Hernández-Weigand P; Reaño M; Pérez-Pimiento A; Vargas Núñez JA; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(7):621-2. PubMed ID: 21314007
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of allergy by oral hyposensitization].
    Iorde V; Latsinik G
    Klin Med (Mosk); 1996; 74(4):27-9. PubMed ID: 8999146
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyposensitization in allergic diseases?].
    Fuchs E
    Dtsch Med Wochenschr; 1988 Jun; 113(25):1025-8. PubMed ID: 3289877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic desensitization].
    Valovirta E
    Duodecim; 1998; 114(17):1739-46. PubMed ID: 11717782
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of allergen immunotherapy. Shortened version of a World Health Organisation/International Union of Immunological Societies Working Group Report.
    Lancet; 1989 Feb; 1(8632):259-61. PubMed ID: 2563421
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of accelerated hyposensitization with mixed allergens in severe childhood asthma].
    Just J; Bodart E; Pothel E; Boulé M; Grimfeld A; Tournier G
    Ann Pediatr (Paris); 1992 Apr; 39(4):236-40. PubMed ID: 1616237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials with recombinant allergens: research studies?
    Pauli G
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
    [No Abstract]   [Full Text] [Related]  

  • 13. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of the innate immune function of dendritic cells by allergen-specific immunotherapy.
    Bellinghausen I
    Clin Exp Allergy; 2010 Jan; 40(1):12-4. PubMed ID: 20205693
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in allergen immunotherapy.
    Stone D; Imbeau S; Moyer J
    J S C Med Assoc; 2000 May; 96(5):218-20. PubMed ID: 10850024
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comment on the article: Hyposensitization therapy--quo vadis?].
    Kompa HE
    Z Hautkr; 1990 Jul; 65(7):645-6. PubMed ID: 2399755
    [No Abstract]   [Full Text] [Related]  

  • 18. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
    Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
    J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
    [No Abstract]   [Full Text] [Related]  

  • 19. New routes and formulations for allergen-specific immunotherapy.
    Wheeler AW; Drachenberg KJ
    Allergy; 1997 Jun; 52(6):602-12. PubMed ID: 9226053
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of rush subcutaneous immunotherapy administered in real life using an infusion pump.
    Uriarte Obando SA; Sastre Domínguez J
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):527-9. PubMed ID: 26460294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.